AGT and metabolic disease: Metabolic disorders can activate renin-angiotensin-aldosterone system (RAAS), increase angiotensin II and aldosterone activity, which leads to cardiomyocyte hypertrophy, increased cardiac fibroblast proliferation and myocardial remodeling acceleration (32, 34).